In order to evaluate the most appropriate system for downstream molecular characterization at the gene expression and DNA methylation analysis level in CTCs from HNSCC patients, we performed for the first time a direct comparison study, using identical blood draws, between a label-independent size-based microfluidic device and an EpCAM-based CTC enrichment system. Here, EPCAM is linked to head and neck squamous cell carcinoma.